Literature DB >> 2999239

The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo.

V J Dindzans, P J MacPhee, L S Fung, J L Leibowitz, G A Levy.   

Abstract

After infection with 10(3) plaque-forming units of mouse hepatitis virus strain 3 (MHV-3) in vivo, peripheral blood mononuclear cells and splenic cells expressed procoagulant activity (PCA) in a pattern directly correlating with susceptibility to disease. Mononuclear cells from BALB/cJ mice, a strain which is fully susceptible to MHV-3, expressed a greater than 500-fold increase in PCA. PCA was first detected within 12 hr of infection; prior to histologic evidence of disease and viral replication, it reached maximal levels 48 hr post-infection (p.i.) and persisted until the death of the animals 5 to 7 days p.i. Mononuclear cells from C3HeB/FeJ mice expressed a significant but lesser titer of PCA, with elevated PCA persisting throughout the chronically infected state until death of the animals 4 to 6 mo p.i. Basal levels of PCA were detected in mononuclear cells from fully resistant A/J mice despite the presence of large amounts of virus in livers, spleens, and sera from these animals. When mononuclear cells expressing high PCA were subfractionated, monocytes were found to be the cellular source of greater than 96% of the PCA activity. Increased plasminogen activator activity was found in monocytes from resistant A/J mice at the time when PCA was markedly elevated in BALB/cJ and C3HeB/FeJ mice. This activity persisted for 5 to 7 days p.i., but was undetectable 10 days p.i. at a time when the mice had cleared the virus from their blood streams. These observations suggest that monocyte PCA may be important in the pathogenesis of MHV-3 disease, whereas the production of monocyte plasminogen activators may contribute to resistance of A/J mice to MHV-3-induced liver disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999239

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice.

Authors:  Nadine De Albuquerque; Ehtesham Baig; Xuezhong Ma; Jianhua Zhang; William He; Andrea Rowe; Marlena Habal; Mingfeng Liu; Itay Shalev; Gregory P Downey; Reginald Gorczynski; Jagdish Butany; Julian Leibowitz; Susan R Weiss; Ian D McGilvray; M James Phillips; Eleanor N Fish; Gary A Levy
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

2.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response.

Authors:  S T Fan; T S Edgington
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

Authors:  R J Fingerote; M Abecassis; M J Phillips; Y S Rao; E H Cole; J Leibowitz; G A Levy
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Disparate mechanisms of induction of procoagulant activity by live and inactivated bacteria and viruses.

Authors:  S B Sinclair; O D Rotstein; G A Levy
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Role of macrophages, interferon gamma and procoagulant activity in the resistance of genetic heterogeneous mouse populations to mouse hepatitis virus infection.

Authors:  R C Vassão; I G Mello; C A Pereira
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity.

Authors:  R L Parr; L Fung; J Reneker; N Myers-Mason; J L Leibowitz; G Levy
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.

Authors:  M Pope; O Rotstein; E Cole; S Sinclair; R Parr; B Cruz; R Fingerote; S Chung; R Gorczynski; L Fung
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3.

Authors:  P J MacPhee; V J Dindzans; L S Fung; G A Levy
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.